OBJECTIVE: To investigate the economic effects of three chemotherapy schemes in the treatment of non-small cell lung cancer(NSCLC).METHODS:114 cases of advanced NSCLC were randomly divided into 3 groups, group MVP, group NP and group TP. The cost effectiveness of the 3 groups were compared using pharmaceutical economics. RESULTS: 3 schemes costed 1 875.2 yuan,5 565.2 yuan and 8 369.6 yuan respectively; The effective rates were 33.2%,34.1% and 40.5% respectively. On the basis of scheme MVP, scheme NP and TP increased cost of 4 100 yuan and 889.64 yuan respectively for 1% increase in effective rate. CONCLUSION: Scheme TP is the preferred choice.